News & Updates

Pain mechanisms tied to disease activity in DMARD-treated RA
Pain mechanisms tied to disease activity in DMARD-treated RA
15 Jun 2023
Post-treatment HBsAg loss greater with TDF vs entecavir
Post-treatment HBsAg loss greater with TDF vs entecavir
12 Jun 2023

In patients with chronic hepatitis B (CHB) without cirrhosis, the rates of hepatitis B surface antigen (HBsAg) loss appear to be higher after discontinuation of tenofovir disoproxil fumarate (TDF) than of entecavir, and this is particularly true for patients who have not experienced relapse after treatment discontinuation, according to a study.

Post-treatment HBsAg loss greater with TDF vs entecavir
12 Jun 2023